نتائج البحث - "Elena Bonazzoli"

1

Academic Journal

Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo

المصدر: Molecular Oncology, Vol 14, Iss 3, Pp 645-656 (2020)

مصطلحات موضوعية: antibody–drug conjugate, endometrial carcinoma, IMMU‐132, sacituzumab govitecan, uterine cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1574-7891; https://doaj.org/toc/1878-0261

URL الوصول: https://doaj.org/article/4855a08bc9b94673965f1e87191a9728

View record in DOAJ

Full Text Finder

2

Academic Journal

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer

المصدر: Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: sacituzumab govitecan, ovarian carcinoma, antibody drug conjugate (ADC), Trop-2, target therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fonc.2020.00118/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/2f3ecf6859594b69a06c011b962dbb6a

View record in DOAJ

Full Text Finder

3

Data from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma

المؤلفون: Alessandro D. Santin, Eric Song, Akiko Iwasaki, Elena Bonazzoli, Tobias M.P. Hartwich, Stefania Bellone, Tai Michaels, Ryan D. Chow

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da88eee303de9332363880f5376701f
https://doi.org/10.1158/2159-8290.c.6549732

View record in OpenAIRE

4

Table S2 from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma

المؤلفون: Alessandro D. Santin, Eric Song, Akiko Iwasaki, Elena Bonazzoli, Tobias M.P. Hartwich, Stefania Bellone, Tai Michaels, Ryan D. Chow

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c465296705318e3e3cace41ee662d09
https://doi.org/10.1158/2159-8290.22541712.v1

View record in OpenAIRE

5

Supplementary Figures from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma

المؤلفون: Alessandro D. Santin, Eric Song, Akiko Iwasaki, Elena Bonazzoli, Tobias M.P. Hartwich, Stefania Bellone, Tai Michaels, Ryan D. Chow

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b436c88578411c40e95ea3706bbe79
https://doi.org/10.1158/2159-8290.22541718.v1

View record in OpenAIRE

6

Supplementary Figure 1 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47bbbe8a69d698bc12b43acf09e5e3e
https://doi.org/10.1158/1535-7163.22504590.v1

View record in OpenAIRE

7

Supplementary Figure S4 from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

المؤلفون: Alessandro D. Santin, Roberto Angioli, Corrado Terranova, Peter E. Schwartz, Masoud Azodi, Dan-Arin Silasi, Elena Ratner, Diana P. English, Carlton L. Schwab, Francesca Ferrari, Federica Predolini, Elena Bonazzoli, Stefania Bellone, Jonathan Black, Emiliano Cocco, Salvatore Lopez

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1931808600d23f42f355fd68e86dd55f
https://doi.org/10.1158/1535-7163.22507027.v1

View record in OpenAIRE

8

Supporting Information from Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85cc6f12ded653f5d436b438a15835e6
https://doi.org/10.1158/1535-7163.22504240.v1

View record in OpenAIRE

9

Supplementary Figure 2 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab78a65c7648dc7729220df637ca7280
https://doi.org/10.1158/1535-7163.22507497.v1

View record in OpenAIRE

10

Data from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::96803aeb0319979ba122bff602aec038
https://doi.org/10.1158/1535-7163.c.6538710.v1

View record in OpenAIRE

11

Data from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a81646ed0c38f7c706dc160a71539783
https://doi.org/10.1158/1535-7163.c.6537780.v1

View record in OpenAIRE

12

Supplementary Figure 3 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53be3b3c29dfd1353c8c582dd60bb588
https://doi.org/10.1158/1535-7163.22504572

View record in OpenAIRE

13

Supplementary Table 1 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fcb104cd92d2f0894168c7c28a76f30
https://doi.org/10.1158/1535-7163.22507494

View record in OpenAIRE

14

Supplementary Table 1 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84041e0d44be22aecf17d287e5cd0946
https://doi.org/10.1158/1535-7163.22504569.v1

View record in OpenAIRE

15

Data from Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo

المؤلفون: Alessandro D. Santin, Roberto Angioli, Corrado Terranova, Peter E. Schwartz, Masoud Azodi, Dan-Arin Silasi, Elena Ratner, Diana P. English, Carlton L. Schwab, Francesca Ferrari, Federica Predolini, Elena Bonazzoli, Stefania Bellone, Jonathan Black, Emiliano Cocco, Salvatore Lopez

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::555351520ca72ed5eb7a05fb2b816b68
https://doi.org/10.1158/1535-7163.c.6538558.v1

View record in OpenAIRE

16

Supplementary Figure 2 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f04ff34ea7724140d47131b6dc949bf
https://doi.org/10.1158/1535-7163.22504578.v1

View record in OpenAIRE

17

Supplementary Figure 1 from SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e2220e5b32e4b1ff6c1ddf00e632828
https://doi.org/10.1158/1535-7163.22507500.v1

View record in OpenAIRE

18

Supplementary Table 2 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbde51b17c657f4a6a454c2aa795846
https://doi.org/10.1158/1535-7163.22504566

View record in OpenAIRE

19

Data from Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ce4a796a67f584d37404a4e0c9053a
https://doi.org/10.1158/1078-0432.c.6527471.v1

View record in OpenAIRE

20

Table S1 from Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f9650fed185b3433dce0c92215b4b1
https://doi.org/10.1158/1078-0432.22470236.v1

View record in OpenAIRE

تنقيح النتائج